Halozyme Therapeutics Inc. buy Benchmark Co.

Summary

This prediction is currently active. The prediction currently has a performance of 11.77%. This prediction currently runs until 03.02.27. The prediction end date can be changed by Benchmark_Co_ at any time. Benchmark_Co_ has 50% into this prediction

Performance without dividends (%)

Name	1w	1m
Halozyme Therapeutics Inc.	-0.666%	-0.666%
iShares Core DAX®	2,59 %	2,47 %
iShares Nasdaq 100	-0,91 %	-6,46 %
iShares Nikkei 225®	0,15 %	-8,77 %
iShares S&P 500	-0,37 %	-1,22 %